Results 201 to 210 of about 14,810 (242)

Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia. [PDF]

open access: yesHemasphere
Rodríguez-Ruiz L   +15 more
europepmc   +1 more source

Ethics and eplerenone

Journal of Medical Ethics, 2012
The use of a placebo arm in clinical trials is unethical if there is an active comparator that is acceptably safe and effective. We argue that reasonable evidence of effectiveness and safety of an inexpensive alternative to an expensive therapy is sufficient to require that the inexpensive therapy be included as a comparator when the expensive therapy ...
Shruti, Gupta   +2 more
openaire   +2 more sources

Eplerenone in hypertension

Expert Opinion on Pharmacotherapy, 2004
Appreciation of the role of aldosterone in cardiovascular and renal disease has increased in the last 50 years. The use of spironolactone was limited by adverse sexual effects, including gynaecomastia. Eplerenone is a newer aldosterone antagonist that is much more selective, with minimal affinity for progesterone and androgenic receptors; therefore ...
openaire   +2 more sources

Eplerenone

Reactions Weekly, 2022
openaire   +2 more sources

Eplerenone. Pharmacia.

Current opinion in investigational drugs (London, England : 2000), 2003
Pharmacia Corp (formerly GD Searle & Co) is developing eplerenone, an aldosterone receptor antagonist, as a potential treatment for congestive heart failure and systemic hypertension. The compound has been registered for hypertension and Pharmacia plans to submit a supplemental NDA for congestive heart failure in the first half of 2003 based on ...
Liew, Danny   +2 more
openaire   +1 more source

▼Eplerenone after myocardial infarction?

Drug and Therapeutics Bulletin, 2008
Each year in the UK, an estimated 50,000 patients develop major left ventricular systolic dysfunction (LVSD) and heart failure following a myocardial infarct.1 Such patients have a particularly poor prognosis.2 ▼Eplerenone (Inspra – Pfizer) is an aldosterone-receptor antagonist for patients who have LVSD and heart failure following a recent myocardial ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy